IPP Bureau
Indian pharma market grew by 13.7% in July 2021: Ind-Ra
By IPP Bureau - August 12, 2021
Demand normalisation post the second wave contributed to the steady growth
Mangalam Drugs signs tech transfer agreement with Nigerian pharma company
By IPP Bureau - August 12, 2021
Anti-malaria API facility will be operational in 15-18 months
Aster DM Healthcare PAT at Rs 44.47 crores for Q1FY22
By IPP Bureau - August 12, 2021
Income declines marginally
Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%
By IPP Bureau - August 12, 2021
It’s an AB-rated generic therapeutic version of Durezol
KK Pant is the new NPPA chairman
By IPP Bureau - August 12, 2021
It plays a pivotal role in monitoring pharmaceutical pricing
Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness
By IPP Bureau - August 12, 2021
A treatment to prevent extreme symptoms and cut hospitalisation
Research demonstrates Hoth Therapeutics HT-KIT for mast cell cancers reduces size and spread
By IPP Bureau - August 12, 2021
Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm
Global cell expansion market poised for huge growth
By IPP Bureau - August 12, 2021
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
SAB Biotherapeutics nonclinical data indicates SAB-185 neutralizes Delta and Lambda SARS-CoV-2 Variants
By IPP Bureau - August 12, 2021
SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial
Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee
By IPP Bureau - August 12, 2021
The company is eligible for 12 months exclusivity from launch
Low-cost flexible tactile sensors for robotics and biomedical applications developed
By IPP Bureau - August 12, 2021
The sensors have been tested for their different level of strains like micro and large scale motion monitoring and have potential applications in biomedical devices, skin electronics, and minimally invasive surgery
Natco Pharma PAT at Rs 75 crore for Q1FY22
By IPP Bureau - August 12, 2021
The company has strong product launches both in India and overseas
Hester Biosciences posts PAT of Rs 11.01 cr in Q1FY22
By IPP Bureau - August 12, 2021
The sales of vaccines have registered a growth of 41% in Q1 FY22, and the sale of health products have registered a growth of 94% in Q1 FY22.
New CAP guideline improves diagnoses of patients with Monoclonal Gammopathies
By IPP Bureau - August 11, 2021
The American Association for Clinical Chemistry (AACC); the American Society for Clinical Pathology (ASCP); the American Society of Hematology (ASH); and the International Myeloma Working Group (IMWG), collaborate to develop the guideline
FUJIFILM Irvine Scientific appointed global distributor of Presagen’s Life Whisperer
By IPP Bureau - August 11, 2021
High-resolution image-based ART workflow software uses artificial intelligence to provide objective embryo grading, to assist embryologists during embryo selection
